Wenger, Alice http://orcid.org/0000-0001-5133-7074
Biran, Alva http://orcid.org/0000-0002-0276-2004
Alcaraz, Nicolas
Redó-Riveiro, Alba http://orcid.org/0000-0002-7015-2486
Sell, Annika Charlotte
Krautz, Robert
Flury, Valentin http://orcid.org/0000-0003-0476-4940
Reverón-Gómez, Nazaret
Solis-Mezarino, Victor
Völker-Albert, Moritz
Imhof, Axel http://orcid.org/0000-0003-2993-8249
Andersson, Robin http://orcid.org/0000-0003-1516-879X
Brickman, Joshua M. http://orcid.org/0000-0003-1580-7491
Groth, Anja http://orcid.org/0000-0003-0577-1771
Article History
Received: 26 April 2022
Accepted: 17 July 2023
First Online: 4 September 2023
Competing interests
: A.G. is cofounder and CSO of Ankrin Therapeutics. V.S., M.V.A. and A.I. are cofounders of EpiQMAx GmbH. All other authors declare that they have no competing interests.